Related Experiment Video
Updated: Oct 2, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Gla-Rich Protein, Magnesium and Phosphate Associate with Mitral and Aortic Valves Calcification in Diabetic Patients
Ana P Silva1,2, Carla S B Viegas3,4, Patrícia Guilherme5
1Department of Nephrology, Centro Hospitalar Universitário do Algarve, 8000-386 Faro, Portugal.
Insights
Low Gla-rich protein (GRP) levels are linked to heart valve calcification in chronic kidney disease (CKD) patients. This finding suggests GRP may aid in early cardiovascular risk assessment for CKD individuals.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Cardiovascular calcification, particularly valvular calcification (VC), is prevalent and a significant mortality predictor in chronic kidney disease (CKD) patients.
- Early diagnosis of VC is challenging due to a lack of validated biomarkers.
- Gla-rich protein (GRP) is identified as a potential inhibitor of cardiovascular calcification.
Purpose of the Study:
- To investigate the association between serum Gla-rich protein (GRP) levels and the presence of mitral and aortic valve calcification (VC) in diabetic patients with CKD stages 2-4.
- To evaluate GRP as a potential diagnostic biomarker for VC in this high-risk population.
Main Methods:
- A cohort of 80 diabetic patients with CKD stages 2-4 was studied.
- Serum GRP levels were measured and correlated with the presence of mitral and aortic valve calcification.
- Statistical analyses, including univariate, multivariate, and Poisson regression, were performed, alongside Receiver Operating Characteristic (ROC) curve analysis.
Main Results:
- Valvular calcification (VC) was detected in 36.2% (mitral) and 34.4% (aortic) of patients.
- Lower serum GRP levels were significantly associated with both mitral and aortic VC, independent of age and gender.
- Low GRP and magnesium (Mg), and high phosphate (P) levels were associated with VC. GRP demonstrated higher diagnostic value (AUC for mitral: 0.762, aortic: 0.802) compared to Mg and P.
Conclusions:
- Low serum GRP levels, along with low magnesium and high phosphate, are independent and cumulative risk factors for valvular calcification (VC) in diabetic CKD patients.
- GRP shows potential as a useful biomarker for cardiovascular risk assessment in this population.
- Further research is warranted to validate GRP's role in predicting VC and cardiovascular outcomes in CKD.
Abstract:
Accelerated and premature cardiovascular calcification is a hallmark of chronic kidney disease (CKD) patients. Valvular calcification (VC) is a critical indicator of cardiovascular disease and all-cause mortality in this population, lacking validated biomarkers for early diagnosis. Gla-rich protein (GRP) is a cardiovascular calcification inhibitor recently associated with vascular calcification, pulse pressure, mineral metabolism markers and kidney function. Here, we examined the association between GRP serum levels and mitral and aortic valves calcification in a cohort of 80 diabetic patients with CKD stages 2-4. Mitral and aortic valves calcification were detected in 36.2% and 34.4% of the patients and associated with lower GRP levels, even after adjustments for age and gender. In this pilot study, univariate, multivariate and Poisson regression analysis, show that low levels of GRP and magnesium (Mg), and high levels of phosphate (P) are associated with mitral and aortic valves calcification. Receiver operating characteristic (ROC) curves showed that the area under the curve (AUC) values of GRP for mitral (0.762) and aortic (0.802) valves calcification were higher than those of Mg and P. These results suggest that low levels of GRP and Mg, and high levels of P, are independent and cumulative risk factors for VC in this population; the GRP diagnostic value might be potentially useful in cardiovascular risk assessment.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction

